Therapeutic Proteins and Oral Vaccines Market

Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.
Therapeutic Proteins and Oral Vaccines Market contains market size and forecasts of Therapeutic Proteins and Oral Vaccines in Global, including the following market information:
Global Therapeutic Proteins and Oral Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Therapeutic Proteins and Oral Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutic Proteins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Proteins and Oral Vaccines include Abbott, Amgen, Biogen, Eli Lilly and Company, Roche, Johnson and Johnson, Merck, Novo Nordisk and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Therapeutic Proteins and Oral Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Proteins and Oral Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, by Type, 2021 (%)
Therapeutic Proteins
Oral Vaccines
Global Therapeutic Proteins and Oral Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Therapeutic Proteins and Oral Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Proteins and Oral Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Therapeutic Proteins and Oral Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience